Spero Therapeutics
Price & Volume
Stats
See more52W Range | $0.74-$1.89 |
Market Cap | $42.2M |
Shares Short | 429,588 |
Financials
See moreRevenue (12 Mos) | $106.4M |
Revenue Growth (YoY) | -47.1% |
Gross Profit (12 Mos) | $54.8M |
Diluted EPS | $0.08 |
News
See moreYahoo Finance • 7 days ago
UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Yahoo Finance • last year
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Spero Therapeutics Inc. (NASDAQ: SPRO)
Yahoo Finance • last year
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
Yahoo Finance • last year
Spero Therapeutics to Present at Upcoming November Investor Conferences
About
CEO | Ms. Esther P. Rajavelu |
CFO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 46 |
